Skip to content

Clinical trials

Respiratory Syncytial Virus Infections trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Country / region: Australia Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20081
20101
20131
20144
20155
20163
20182
20193
20202
20213
20232
20248
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Active, not recruiting4
Terminated4
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline10
Sanofi Pasteur, a Sanofi Company4
MedImmune LLC3
Shanghai Ark Biopharmaceutical Co., Ltd.3
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.2
Alios Biopharma Inc.2
Alnylam Pharmaceuticals2
Clover Biopharmaceuticals AUS Pty2
Gilead Sciences2
Janssen Sciences Ireland UC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections43
Virus Diseases4
Paramyxoviridae Infections2
Influenza, Human1
Premature Birth1
Respiratory Tract Infections1

Trials

Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.